Tag: Bharat Biotech Intranasal Vaccine

COVAXIN Maker Bharat Biotech Intranasal Vaccine (BBV154) Approved for Phase 3 Clinical Trials

Bharat Biotech Intranasal Vaccine (BBV154) for COVID-19 today received approval from the Drug Controller General of India to

COVAXIN Maker Bharat Biotech Shares 2 Promising Updates Today

COVAXIN - India's COVID-19 vaccine maker Bharat Biotech shared two significant updates that include details about augmenting vaccine